Arrowstreet Capital’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $128M | Buy |
510,516
+210,112
| +70% | +$52.3M | 0.07% | 266 |
|
|
2025
Q4 | $82.7M | Buy |
300,404
+79,440
| +36% | +$21.7M | 0.05% | 340 |
|
|
2025
Q3 | $58M | Buy |
220,964
+91,934
| +71% | +$22.3M | 0.04% | 416 |
|
|
2025
Q2 | $28.2M | Buy |
129,030
+87,679
| +212% | +$18.7M | 0.02% | 579 |
|
|
2025
Q1 | $9.26M | Buy |
+41,351
| New | +$11.4M | 0.01% | 828 |
|
|
2023
Q2 | – | Sell |
-4,508
| Closed | -$1.56M | – | 1503 |
|
|
2023
Q1 | $1.56M | Buy |
4,508
+3,298
| +273% | +$964K | ﹤0.01% | 967 |
|
|
2022
Q4 | $285K | Buy |
+1,210
| New | +$287K | ﹤0.01% | 1215 |
|
|
2022
Q3 | – | Sell |
-77,108
| Closed | -$23.3M | – | 1480 |
|
|
2022
Q2 | $23.3M | Sell |
77,108
-179,585
| -70% | -$58.4M | 0.03% | 349 |
|
|
2022
Q1 | $105M | Sell |
256,693
-250,181
| -49% | -$97.9M | 0.13% | 168 |
|
|
2021
Q4 | $238M | Sell |
506,874
-8,274
| -2% | -$3.56M | 0.29% | 82 |
|
|
2021
Q3 | $219M | Buy |
515,148
+153,180
| +42% | +$64.6M | 0.27% | 83 |
|
|
2021
Q2 | $130M | Sell |
361,968
-16,395
| -4% | -$5.42M | 0.16% | 138 |
|
|
2021
Q1 | $107M | Buy |
378,363
+129,527
| +52% | +$37.1M | 0.14% | 144 |
|
|
2020
Q4 | $70.5M | Buy |
248,836
+62,320
| +33% | +$17.5M | 0.1% | 186 |
|
|
2020
Q3 | $51.3M | Buy |
186,516
+162,003
| +661% | +$42.9M | 0.08% | 234 |
|
|
2020
Q2 | $5.57M | Sell |
24,513
-76,210
| -76% | -$15M | 0.01% | 1020 |
|
|
2020
Q1 | $15.3M | Buy |
100,723
+65,588
| +187% | +$10.1M | 0.04% | 363 |
|
|
2019
Q4 | $5.28M | Sell |
35,135
-103,467
| -75% | -$15.1M | 0.01% | 840 |
|
|
2019
Q3 | $19.7M | Buy |
138,602
+26,429
| +24% | +$3.64M | 0.05% | 348 |
|
|
2019
Q2 | $14M | Buy |
112,173
+33,562
| +43% | +$3.96M | 0.03% | 406 |
|
|
2019
Q1 | $8.66M | Buy |
+78,611
| New | +$8.18M | 0.02% | 601 |
|
|
2018
Q3 | – | Sell |
-11,700
| Closed | -$1.16M | – | 1281 |
|
|
2018
Q2 | $1.16M | Buy |
+11,700
| New | +$1.08M | ﹤0.01% | 774 |
|
|
2017
Q4 | – | Sell |
-3,800
| Closed | -$366K | – | 1416 |
|
|
2017
Q3 | $366K | Sell |
3,800
-137,113
| -97% | -$12.4M | ﹤0.01% | 980 |
|
|
2017
Q2 | $13.3M | Buy |
140,913
+84,100
| +148% | +$7.74M | 0.04% | 315 |
|
|
2017
Q1 | $4.64M | Buy |
+56,813
| New | +$4.75M | 0.02% | 587 |
|
|
2016
Q3 | – | Sell |
-5,000
| Closed | -$379K | – | 1656 |
|
|
2016
Q2 | $379K | Buy |
+5,000
| New | +$364K | ﹤0.01% | 1191 |
|
|
2014
Q3 | – | Sell |
-28,455
| Closed | -$1.2M | – | 1138 |
|
|
2014
Q2 | $1.2M | Sell |
28,455
-107,764
| -79% | -$4.62M | 0.01% | 682 |
|
|
2014
Q1 | $6M | Buy |
+136,219
| New | +$6.41M | 0.04% | 404 |
|
Other funds holding WST
VCM
VPM
GIM
